Veröffentlichungen 2009

1. Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O; MSDS study group. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin 2009;48(3):89-98.

2. Buchmann I, Meyer RG, Mier W, Haberkorn U. Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity? Eur J Nucl Med Mol Imaging 2009;36(3):484-98.

3. Burchardt C, Riss PJ, Zoller F, Maschauer S, Prante O, Kuwert T, Roesch F. [(68)Ga]Ga-DO(2)A-(OBu-l-tyr)(2): synthesis, (68)Ga-radiolabeling and in vitro studies of a novel (68)Ga-DO(2)A-tyrosine conjugate as potential tumor tracer for PET. Bioorg Med Chem Lett 2009;19(13):3498-3501.

4. Dimitrakopoulou-Strauss A, Hoffmann M, Bergner R, Uppenkamp M, Haberkorn U, Strauss LG. Prediction of Progression Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET. Clin Nucl Med 2009;34:576-584.

5. García Boy R, Mier W, Nothelfer EM, Altmann A, Eisenhut M, Kolmar H, Tomaszowski M, Krämer S, Haberkorn U. Sunflower Trypsin Inhibitor 1 Derivatives as Molecular Scaffolds for the Development of Novel Peptidic Radiopharmaceuticals. Mol Imaging Biol 2009; Nov 24 [Epub ahead of print].

6. Giesel FL, Mehndiratta A, Locklin J, McAuliffe MJ, White S, Choyke PL, Knopp MV, Wood BJ, Haberkorn U, von Tengg-Kobligk H. Image fusion using CT, MRI and PET for treatment planning, navigation and follow up in percutaneous RFA. Exp Oncol 2009;31(2):106-14.

7. Giesel FL, Mehndiratta A, Risse F, Rius M, Zechmann CM, von Tengg-Kobligk H, Gerigk L, Kauczor HU, Politi M, Essig M, Griffiths PD, Wilkinson ID. Intraindividual Comparison between Gadopentetate Dimeglumine and Gadobutrol for Magnetic Resonance Perfusion in Normal Brain and Intracranial Tumors at 3 Tesla. Acta Radiol 2009;50:521-530.

8. Giesel FL, Mehndiratta A, von Tengg-Kobligk H, Schaeffer A, Teh K, Hoffman EA, Kauczor HU, Beek EJRv, Wild JM. Rapid Prototyping Raw Models on the Basis of High Resolution Computed Tomography Lung Data for Respiratory Flow Dynamics. Acad Radiol 2009;16:495–498.

9. Giesel FL, Delorme S, Sibbel R, Kauczor HU, Krix M. Contrast-enhanced ultrasound for the characterization of incidental liver lesions - an economical evaluation in comparison with multi-phase computed tomography. Ultraschall Med 2009;30(3):259-68.

10. Giesel FL, Hart AR, Hahn HK, Rengier F, Talanow R, Wilkinson ID, Zechmann CM, Weber MA, Kauczor HU, Essig M, Griffiths PD. 3D-Reconstructions of the Cerebral Ventricles and Volume Quantification in Children with Brain Malformations. Acad Radiol 2009;16(5):610-7.

11. Giesel FL, Runge V, Kirchin M, Gerigk L, Corell B, Gendron J, Kauczor HU, Laub G, Essig M. 3-D multiphase time resolved low dose contrast enhanced MR angiography using TWIST on a 32-channel coil at 3 Tesla: quantitative and qualitative comparison of a conventional gadolinium chelate with a high relaxivity agent. Journal of assisted computed tomography 2009; in print.

12. Haberkorn U, Eisenhut M, Altmann A, Mier W. Molecular endoradiotherapy of cancer. Minerva Biotec 2009;21:5-19.

13. Hagist S, Sültmann H, Millonig G, Hebling U, Kieslich D, Kuner R, Balaquer S, Seitz HK, Poustka A, Mueller S. In vitro targeted gene identification in patients with hepatitis C using a genome-wide microarray technology. Hepatology 2009;49(2):378-86.

14. Hilgard P, Müller S, Hamami M, Sauerwein WS, Haberkorn U, Gerken G, Antoch G. Selektive interne Radiotherapie (Radioembolisation) und Strahlentherapie beim HCC - Stand und Perspektiven. Z Gastroenterol 2009;47(1):37-54.

15. Hofele C, Freier K, Thiele OC, Haberkorn U, Buchmann I. High 2-[(18)F]fluoro-2-deoxy-d-glucose ((18)FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol 2009;45(11):963-7.

16. Kasper B, Schmitt T, Wuchter P, Dimitrakopoulou-Strauss A, Ho AD, Egerer G. The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin. Mar Drugs 2009;7:331-340.

17. Kronmüller KT, Schröder J, Köhler S, Götz B, Victor D, Unger J, Giesel F, Magnotta V, Mundt C, Essig M, Pantel J. Hippocampal volume in first episode and recurrent depression. Psychiatry Research: Neuroimaging 2009;174:62–66.

18. Lutz K, Giesel FL, Zechmann CM. Knöcherne Raumforderung am lumbosakralen Übergang bei maligner Grunderkrankung. Radiologe 2009;49:154–157.

19. Mai SK, Welzel G, Hermann B, Wenz F, Haberkorn U, Dinter DJ. Can the Radiation Dose to CT-Enlarged but FDG-PET-Negative Inguinal Lymph Nodes in Anal Cancer Be Reduced? Strahlenther Onkol 2009;185(4):254-259.

20. Mehndiratta A, Knopp MV, Zechmann CM, Owsijewitsch M, von Tengg-Kobligk H, Zamecnik P, Kauczor HU, Choyke PL, Giesel FL. Comparison of diagnostic quality and accuracy in color-coded versus gray-scale DCE-MR imaging display. Int J CARS 2009;4:457–462.

21. Millonig G, Giesel FL, Reimann FM, Topalidis T, Seitz HK, Mueller S. Gastrointestinal Stromal Tumor in a Patient with Undiagnosed Neurofibromatosis Type I: an Uncommon Cause of Extrahepatic Cholestasis. Ein gastrointestinaler Stromatumor in einem Patienten mit unerkannter Neurofibromatose Typ I – eine seltene Ursache für extrahepatische Cholestase. Z Gastroenterol 2009;47:1–3.

22. Mutschler J, Steinbach G, Bunjes D, Reske SN, Buchmann I. Myeloablative radioimmunotherapy with (188)Re-CD66mAb before stem cell transplantation. No increase of proinflammatory cytokine levels of TNF-alpha. Nuklearmedizin 2009;48(1):30-36.

23. Neeb D, Kunz RP, Ley S, Szábo G, Strauss LG, Kauczor HU, Kreitner KF, Schreiber LM. Quantification of pulmonary blood flow (PBF): Validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with (H2O)-O-15 positron emission tomography (PET). Magn Reson Med 2009;62(2):476-487.

24. Nimmagadda S, Mangner TJ, Lawhorn-Crews JM, Haberkorn U, Shields AF. Herpes simplex virus thymidine kinase imaging in mice with (1-(2'-deoxy-2'-[(18)F]fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil) and metabolite (1-(2'-deoxy-2'-[(18)F]fluoro-1-beta-D-arabinofuranosyl)-5-uracil). Eur J Nucl Med Mol Imaging 2009;36(12):1987-1993.

25. Nothelfer EM, Zitzmann-Kolbe S, Garcia-Boy R, Krämer S, Herold-Mende C, Altmann A, Eisenhut M, Mier W, Haberkorn U. Identification and Characterization of a Peptide with Affinity to Head and Neck Cancer. J Nucl Med 2009;50(3):426-34.

26. Okazumi S, Dimitrakopoulou-Strauss A, Schwarzbach MHM, Strauss LG. Quantitative, dynamic 18F-FDG-PET for the evaluation of soft tissue sarcomas: elation to differential diagnosis, tumor grading and prediction of prognosis. Hell J Nucl Med 2009;12(3):223-228.

27. Oltmanns D, Eisenhut M, Mier W, Haberkorn U. Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors. Curr Med Chem 2009;16(17):2086-2094.

28. Rengier F, Doll S, von Tengg-Kobligk H, Kirsch J, Kauczor HU, Giesel FL. Integrated teaching of anatomy and radiology using three-dimensional image post-processing. Eur Radiol 2009;19:2870–2877.

29. Rengier F, Weber TF, Giesel FL, Böckler D, Kauczor HU, von Tengg-Kobligk H. Centerline analysis of aortic CT angiographic examinations: benefits and limitations. AJR Am J Roentgenol 2009;192(5):W255-63.

30. Schlotmann A, Clorius JH, Clorius SN. Diuretic renography in hydronephrosis: renal tissue tracer transit predicts functional course and thereby need for surgery. Eur J Nucl Med Mol Imaging 2009;36(10):1665-73.

31. Schönknecht OD, Hunt A, Toro P, Henze M, Haberkorn U, Schröder J. Neural correlates of delayed episodic memory in patients with mild cognitive impairment-A FDG PET study. Neurosci Lett 2009;467(2):100-4.

32. Strauss LG, Dimitrakopoulou-Strauss A. Positron Emission Tomography (PET) and Macromolecular Delivery In Vivo. Methods Mol Biol 2009;480:187-98.

33. Strauss LG, Hoffend J, Koczan D, Pan L, Haberkorn U, Dimitrakopoulou-Strauss A. Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics. Eur J Nucl Med Mol Imaging 2009;36(8):1226-34.

34. Strauss LG, Dimitrakopoulou-Strauss A. The impact of gene expression on (18)F-FDG kinetics; a new chapter for diagnostic nuclear medicine. Hell J Nucl Med 2009;12(1):2-4.

35. Strauss LG, Dimitrakopoulou-Strauss A. Predicting Therapy Outcome with Quantitative PET: What Is Needed and What Can Be Done? Onkologie 2009;32:706–707.

36. Tavitian B, Haberkorn U. Darwinian molecular imaging. Eur J Nucl Med Mol Imaging 2009;36(9):1475-1482.

37. Tengg-Kobligk H von, Ley-Zaporozhan J, Henninger V, Grünberg KM, Giesel FL, Böckler D, Krummenauer F, Kauczor HU, Ley S. Intraindividual Assessment of the Thoracic Aorta using Contrast and Non-Contrast-Enhanced MR Angiography. Intraindividueller Vergleich zwischen nativer und kontrastverstärkter MR-Angiografie der thorakalen Aorta. Fortschr Röntgenstr 2009;181:230-236.

38. Vasamiliette J, Hohenberger P, Schoenberg S, Diehl S, Dinter DJ, Marx A, Stroebel P, Strauss LG, Dimitrakopoulou-Strauss A: Treatment monitoring with 18F-FDG PET in metastatic thymoma after 90Y-Dotatoc and selective internal radiation treatment (SIRT). Hell J Nucl Med 2009;12(3):271-273.

39. Zechmann CM, Aftab K, Didinger B, Giesel FL, Zamecnik P, Thieke C, Fütterer JJ, Kopp-Schneider A, Kauczor HU, Delorme S. Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy – A follow-up study. Radiotherapy and Oncology 2009;90:408–412.

40. Zoller F, Eisenhut M, Haberkorn U, Mier W. Endoradiotherapy in cancer treatment - Basic concepts and future trends. Eur J Pharmacol 2009;625(1-3):55-62.

1. Haberkorn U. What is cancer? In: Bombardieri E, Buscombe J, Lucignani G, Schober O (eds.) Advances in nuclear oncology Diagnosis and Therapy. Informa Healthcare London 2009; pp 1-16. ISBN 1841846147.

2. Haberkorn U, Altmann A, Mier W, Eisenhut M. Molecular imaging of tumor metabolism and apoptosis. In: Kroemer G, Mumberg D, Keun H, Riefke B, Steger-Hartmann T (eds.) Oncogenes Meet Metabolism: From Deregulated Genes to a Broader Understanding of Tumour Physiology (Ernst Schering Foundation Symposium Proceedings). Springer Verlag 2009; pp 125-152. ISBN 9783540794776.

3. Zechmann C. Kapitel Radiologie. In: Mediscript - Hammerexamen 10/2006 - 10/2009 Alle Original-IMPP-Prüfungsfragen des 2. Abschnitts der Ärztlichen Prüfung, CD-Rom. Fecker G, Urban & Fischer bei Elsevier, 2009; ISBN 9783437438907.